Thomas Patton - CAS Medical President CEO, Director

CEO

Mr. Thomas M. Patton is President, Chief Executive Officer, Director of CAS Medical Systems Inc. Mr. Patton has served as CASMEDs President and Chief Executive Officer and as a member of the CASMED Board of Directors since August 2010. He previously served as the CEO of Wright Medical Group, an orthopedic device company, located in Memphis, Tennessee, and as President of Novametrix Medical Systems, a patientmonitoring company, located in Wallingford, Connecticut. From 2003 to 2010, Mr. Patton acted as an advisor to the healthcarefocused private equity group of Ferrer Freeman Company and, in that capacity, served as the interim CEO of Informed Medical Communications on a parttime basis in 2006 and 2007. Mr. Patton is a cofounder and CEO of QDx, Inc., a startup company that developed a platform for hematology diagnostics beginning in 2003. Mr. Patton attended The College of the Holy Cross, where he majored in Economics and Accounting. After graduating magna cum laude from Georgetown University Law Center, Mr. Patton worked at the law firm of Williams Connolly in Washington, D.C. Thereafter, he joined Wright Medical Group as its General Counsel where he served in various executive roles until being appointed CEO. Mr. Patton has extensive experience in the medical device industry and, as President and Chief Executive Officer, provides the Board with primary knowledge of CASMEDs business operations. since 2010.
Age 53
Tenure 14 years
Phone203-488-6056
Webhttp://www.fore-sight.com
Patton attended The College of the Holy Cross where he majored in Economics and Accounting. After graduating magna cum laude from Georgetown University Law Center, Mr. Patton worked at the law firm of Williams & Connolly in Washington, DC. Thereafter, he joined Wright Medical Group as its General Counsel where he served in various executive roles until being appointed CEO.

CAS Medical Management Efficiency

The company has return on total asset (ROA) of (23.57) % which means that it has lost $23.57 on every $100 spent on assets. This is way below average. CAS Medical's management efficiency ratios could be used to measure how well CAS Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 9.38 M in liabilities. CAS Medical Systems has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist CAS Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CAS Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CAS Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CAS to invest in growth at high rates of return. When we think about CAS Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 3 records

CEO Age

Eduardo LombanaCopa Holdings SA
62
Russell ChildsSkyWest
56
Pedro HeilbronCopa Holdings SA
66
CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut. CAS Medical operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 73 people. CAS Medical Systems (CASM) is traded on NASDAQ Exchange in USA and employs 73 people.

Management Performance

CAS Medical Systems Leadership Team

Elected by the shareholders, the CAS Medical's board of directors comprises two types of representatives: CAS Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CAS. The board's role is to monitor CAS Medical's management team and ensure that shareholders' interests are well served. CAS Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CAS Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kenneth Weisshaar, Independent Director
Jeffrey Baird, CFO, Secretary
Kimberly Strusky, Executive Vice President - U.S. Sales
Don Markley, IR Contact Officer
Paul Benni, Chief Scientific Officer
Kathleen Tune, Independent Director
Paul Molloy, Director
James Thomas, Lead Independent Director
Thomas Patton, President CEO, Director
John Gamelin, VP of RandD
Gregory Rainey, Independent Director
Alan Milinazzo, Director

CAS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CAS Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CAS Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAS Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAS Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to NRG Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRG Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRG Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRG Energy to buy it.
The correlation of NRG Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRG Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRG Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRG Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in CAS Stock

If you are still planning to invest in CAS Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CAS Medical's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios